StockNews.AI
MDT
StockNews.AI
37 days

Medtronic to announce financial results for its third quarter of fiscal year 2025

1. Medtronic will report Q3 2025 results on February 18, 2025. 2. Webcast at 7:00 a.m. CST will discuss Q3 2025 financials. 3. Future earnings dates for FY2026 are planned and confirmed.

6 mins saved
Full Article

FAQ

Why Neutral?

Upcoming earnings announcement typically leads to volatility, but initial projections are unclear.

How important is it?

Earnings can significantly impact stock price but depend on actual results versus expectations.

Why Short Term?

Earnings reports often affect prices shortly before and after the announcement.

Related Companies

ABBVJNJCOV
, /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2025 on Tuesday, February 18, 2025. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2025, which ended on Friday, January 24, 2025. Medtronic will host a video webcast at 7:00 a.m. CST on February 18, 2025, to discuss results for its third quarter of full fiscal year 2025. The webcast can be accessed at https://investorrelations.medtronic.com. Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Events link at https://investorrelations.medtronic.com. Looking ahead, Medtronic plans to report its fourth quarter fiscal year 2025 results on Wednesday, May 21, 2025. For fiscal year 2026, Medtronic plans to report its first, second, third, and fourth quarter results on Tuesday, August 19, 2025, November 18, 2025, February 17, 2026, and Wednesday, May 20, 2026, respectively. For these events, confirmation and additional details will be provided closer to the specific event. About MedtronicBold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across more than 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people second, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE: MDT), visit www.Medtronic.com and follow Medtronic on LinkedIn. Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results. Contacts: Erika Winkels                   Ryan Weispfenning Public Relations              Investor Relations +1-763-526-8478            +1-763-505-4626 SOURCE Medtronic plc WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News